Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...

The molecular diagnostics company, which is listed on London’s junior AIM market, launched a consultation process on Monday.

ABL Diagnostics (Paris:ABLD) (Euronext Paris – Compartment B – ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions, healthcare software, and clinical sample management, today ...

Leveraging an annualized run-rate baseline of ~1M€ from late 2025, the Company accelerates its strategic rollout of ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...

Molecular diagnostic techniques are a broad range of laboratory methods that utilise the principles of molecular biology and genetics to identify and diagnose diseases, monitor treatment responses, ...

View Insight Molecular Diagnostics Inc. IMDX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Oliver Bathe calls for policymakers to support molecular risk testing to improve patient care and reduce healthcare costs ...

The growing molecular oncology diagnostics market is fueled by rising global cancer rates and demand for personalized ...

Researchers suggest study is the first to translate cell-free biomanufacturing from laboratory to real-world use, across multiple geographic settings.